What to do when a claimant is prescribed a compounded medication
Evaluating compounded and custom-formulated medications in insurance claims
Published: 3 April 2026 | Updated: 3 April 2026
The scenario
A claimant's pharmacy invoice includes a compounded medication. Not a standard brand-name or generic drug from a mainstream pharmaceutical company, but a custom-compounded prescription, typically made by a compounding pharmacy based on a prescriber's specifications. Cost is AUD 200, 300, or more per month. Your question: is this necessary? Why isn't a standard formulation being used? Should I fund this?
Compounded medications are legitimate in some scenarios, but they warrant closer scrutiny than standard pharmaceuticals. This is where cost, evidence, and clinical necessity intersect.
Understanding compounded medications
Compounded medications are custom-made by pharmacists, typically to specifications provided by a prescriber. This might mean:
- Dose customization: A medication available only in standard doses (e.g., 10mg, 20mg) is compounded at a non-standard dose (e.g., 7mg) to match what the claimant needs
- Formulation adjustment: A medication is reformulated into a liquid, cream, or lozenge when the standard tablet form can't be taken (swallowing difficulty, allergies to tablet binders)
- Combination products: Multiple medications are combined into a single dose (e.g., a pain medication plus muscle relaxant together) for convenience or compliance
- Allergen removal: A medication is compounded without common allergens or binders (gluten-free, dye-free) when the claimant has documented sensitivities
- Bioavailability enhancement: A medication is formulated with additives claimed to improve absorption or effectiveness
Some compounding is medically justified. Some is cosmetic. Some is marketing. Your job is to distinguish.
Key fact: Compounded medications are not regulated with the same rigor as manufactured pharmaceuticals. The active ingredient may be the same, but quality control, consistency, and potency testing are not guaranteed to the same standard. This adds risk if the reason for compounding isn't compelling.
Assessment framework
1. Why is this medication compounded?
This is your starting question. Request from the prescriber explicit clinical justification. What problem does compounding solve? Is a standard formulation unavailable? Is the claimant allergic to something in the standard formulation? Does the claimant have swallowing difficulty or other functional limitation? Is the dose non-standard and unavailable manufactured? Each of these is defensible. "Because the patient prefers it" or "for improved absorption" without specific evidence is not.
2. Is a standard formulation available that would meet the clinical need?
Even if the drug is appropriate, is the compounded version necessary? For example, if a claimant needs a specific dose, check whether a combination of standard tablets would achieve it. If the claimant needs a liquid formulation, confirm that no manufactured liquid exists. If they need allergen-free preparation, verify documented allergies. A standard alternative often exists if you look hard enough.
3. What is the cost comparison?
Compounded medications typically cost 3 to 10 times more than standard formulations. A medication that costs AUD 30 in standard form might cost AUD 200 compounded. Is this cost difference justified by the clinical need? If a claimant has severe difficulty swallowing and genuinely can't take tablets, the extra cost for a liquid may be justified. If the reason is convenience or perceived preference, it's harder to defend the cost.
4. Has the claimant been trialed on standard formulations first?
Did they try the standard form and fail, leading to compounding? Or was compounding chosen without trial of standard therapy? The former is more defensible. The latter suggests the prescriber jumped to a more expensive option without exhausting standard alternatives.
5. Is there documented evidence of benefit from the specific compounded formulation?
Some compounded formulations claim special bioavailability or improved absorption. Request evidence of this benefit. Published trials supporting the specific formulation and dose are strong evidence. Anecdotal prescriber belief is weak evidence. Marketing claims are not evidence.
6. Who prescribed the compounding, and what is their relationship to the compounding pharmacy?
Ideally, the prescriber is independent from the pharmacy. Some prescribers own or have financial relationships with compounding pharmacies, which creates incentive to prescribe compounding. This doesn't automatically mean the prescription is unjustified, but it warrants additional scrutiny.
Common compounding scenarios
Scenario A: Dose customization for pediatric claimant
Example: A child needs an anticonvulsant at 3.5mg/kg/day, which doesn't align with available manufactured doses. It's compounded to the specific dose required.
Your assessment: This is justified compounding. Standard doses don't meet the clinical need. Cost is higher but defensible.
Your action: Fund this. Document the clinical justification. As the claimant grows and weight increases, the dose requirements will change; the compounded prescription should be revisited periodically.
Scenario B: Formulation change for swallowing difficulty
Example: A claimant with severe dysphagia (swallowing difficulty) cannot take tablets. Their medications are compounded into liquids.
Your assessment: Justified. The functional limitation makes standard formulations impossible to take. Compounding solves a real clinical problem.
Your action: Fund this. However, verify that the claimant genuinely has swallowing difficulty (request speech pathology assessment or swallow study confirmation). Some claimants report difficulty but don't have documented dysfunction.
Scenario C: "Bioavailable" or "enhanced absorption" compounded formulation
Example: A compounding pharmacy claims they've formulated a pain medication with additives that improve absorption or provide better pain control than standard forms. Cost is AUD 300/month vs. AUD 40 for standard form.
Your assessment: Weak justification. "Improved absorption" claims often lack rigorous evidence. The active ingredient is the same. The cost difference is not proportionate to any documented benefit.
Your action: Request evidence of benefit from the specific compounded formulation vs. standard therapy. Published trials demonstrating superior efficacy are required. If the prescriber can't provide this, decline the compounded form. Fund standard therapy. Ask the claimant and prescriber to trial standard form first; if there's genuine lack of efficacy, compounding can be reconsidered.
Scenario D: Allergen-free compounding
Example: A claimant has documented allergy to dyes or lactose commonly used in tablets, so medications are compounded without these ingredients.
Your assessment: Justified if allergy is documented. Hypersensitivity or subjective reaction without evidence is weaker justification.
Your action: Request documentation of the allergy (allergy test results, clinical notes confirming reaction). If documented, fund compounding of affected medications. However, some allergies can be managed by switching to alternative standard formulations without compounding. Explore this first.
Scenario E: Multiple medications combined into single compounded dose
Example: A claimant's pain medication, muscle relaxant, and anti-inflammatory are all compounded together into a single dose for convenience.
Your assessment: Weak justification. Combination compounding is typically for convenience or compliance, not medical necessity. Standard tablets taken together achieve the same effect.
Your action: Decline compounding. These can be provided as separate standard medications taken together. The clinical outcome is identical and cost is much lower. If compliance is a concern, address it through other means (dosette boxes, compliance aids, supervised administration).
Red flags for compounding claims
Be skeptical when:
- The prescriber works for or has financial relationship with the compounding pharmacy
- The prescriber claims compounding benefit without evidence (e.g., "absorbed better" without published data)
- Combination compounding is used for convenience rather than medical necessity
- The cost is dramatically higher than standard equivalent without documented clinical need
- The compounding was chosen without trial of standard formulations first
- Multiple claimants are prescribed compounding by the same prescriber (suggests pattern, not individualized need)
- Allergen-free or "special" formulations are claimed without documented allergies
Documentation you need to request
Before approving compounded medication funding, request from the prescriber:
- Explicit clinical justification for why compounding is necessary (not optional)
- Why standard formulations cannot meet the clinical need
- Documentation of trial of standard formulations, if applicable
- For dose customization: explanation of why this specific dose is needed and unavailable manufactured
- For formulation changes: objective clinical documentation of the limitation (e.g., swallow study for dysphagia; allergy test for allergen sensitivity)
- Cost comparison of standard vs. compounded equivalent
- Any evidence of benefit specific to the compounded formulation
- Prescriber's independence from the compounding pharmacy (or disclosure of relationship)
Your decision framework
| Compounding Indication | Evidence Level | Funding Decision |
|---|---|---|
| Dose customization; unavailable in standard form | Strong | Fund |
| Formulation change for documented functional limitation (dysphagia, swallowing difficulty) | Strong | Fund |
| Allergen-free; documented allergy to standard formulation components | Strong | Fund |
| Claimed "improved absorption" or "enhanced bioavailability" without evidence | Weak | Decline; request evidence |
| Combination compounding for convenience | Weak | Decline; use standard separate medications |
| Multiple formulation changes without clear individual justification | Weak | Decline; refer for review |
| Specialty formulation from prescriber-owned or affiliated pharmacy | Weak to moderate | Request disclosure; apply higher scrutiny |
Strategies for cost control
If compounding is justified, manage costs:
- Request competitive quotes: Different compounding pharmacies charge different rates. Get multiple quotes before approving
- Negotiate bulk pricing: If long-term compounding is anticipated, negotiate with the pharmacy for reduced per-unit cost
- Periodically reassess need: As the claimant's condition changes, compounding needs may change. Review annually and decompound medications no longer requiring special formulation
- Document and limit duration: Approve compounding for a defined period, then reassess. Don't allow indefinite compounding without review
When to refer for a medication review
Refer for a pharmacist review when:
- Multiple medications are compounded and rationale is unclear
- Cost is high and you're unsure whether compounding is justified
- The prescriber has financial relationship with the compounding pharmacy
- You want independent assessment of whether compounding is necessary
Key takeaways
- Compounding is legitimate for specific medical reasons; question prescriptions without clear justification
- Prioritize dose customization, functional limitations, and documented allergies as defensible reasons
- Be skeptical of "enhanced absorption" or convenience-based compounding without evidence
- Request documentation of clinical justification and cost comparison
- Fund justified compounding, but manage costs through negotiation and periodic reassessment
- Decline unjustified compounding and request trial of standard formulations
Compounded medication claims creating confusion?
IMM's pharmacists assess compounding necessity, review clinical justification, and identify cost savings by recommending standard formulations where appropriate. We negotiate with compounding pharmacies and provide independent advice on when compounding is truly necessary.
Request a Medication Review
